Primary | Secondary | Function | Studied System | Reference |
---|---|---|---|---|
G protein–dependent signaling | ||||
Primary | ||||
Gαi1 | No activation, but a constitutive recruitment | HEK293 cells | Levoye et al., 2009 | |
No activation | HEK293 cells | Hoffmann et al., 2012 | ||
Gαi/o | ERK/Akt activation | Primary rodent astrocytes | Ödemis et al., 2012 | |
G protein–independent signaling | ||||
Primary | ||||
β-arrestin-1/2 | Akt and MAPK activation | Primary rodent astrocytes | Ödemis et al., 2012 | |
JAK2/STAT3 pathway | Human bladder cancer cells | Hao et al., 2012 | ||
ERK1/2 phosphorylation | Glioma cells | Hattermann et al., 2010 | ||
HEK293 cells | Rajagopal et al., 2010 | |||
No ERK1/2 phosphorylation | Rat VSMCs | Rajagopal et al., 2010 | ||
Internalization | HEK293 cells | Canals et al., 2012 | ||
HEK293 cells | Ray et al., 2012 | |||
Breast cancer cells | Luker et al., 2010 | |||
Akt phosphorylation | PB CD34+ cells | Torossian et al., 2014 | ||
Influence on signaling due to coexpression/oligomerization | ||||
Influence on/oligomer with… | Effect | Secondary Effect | ||
ACKR3 (homomer) | Unknown | HEK293 cells | Levoye et al., 2009 | |
HEK293T cells | Kalatskaya et al., 2009 | |||
α1-AR | Negative regulation of α1-AR | Human VSMCs | Albee et al., 2017 | |
EGFR | CXCR7 involved in phosphorylation of EGFR | Breast cancer cells | Salazar et al., 2014 | |
Mitosis of breast cancer cells | Breast cancer cells | Salazar et al., 2014 | ||
CXCR4 | ACKR3 scavenges CXCL12 from CXCR4 | Fine tuning of primordial germ cell migration | Zebrafish | Boldajipour et al., 2008 |
Daudi cells, MDCK, HeLa cells, Raji B-cells, HUVECs, | Naumann et al., 2010 | |||
zebrafish, mouse hearts, human umbilical cords | ||||
Creating chemokine gradient for migration | Zebrafish lateral line primordium | Donà et al., 2013 | ||
ACKR3 defines directionality of migration | Zebrafish lateral line primordium | Dambly-Chaudière et al., 2009 | ||
ACKR3 negatively modulates CXCR4-mediated lymphocyte integrin adhesiveness | T lymphocytes, CD34+ cells | Hartmann et al., 2008 | ||
Potentiation of Ca2+ fluxa | HEK293 cells | Sierro et al., 2007 | ||
Negative modulation of Ca2+ fluxa | HEK293 cells | Levoye et al., 2009 | ||
Delay of ERK phosphorylation | HEK293 cells | Sierro et al., 2007 | ||
Enhancement of p38 MAPK and SAPK pathways | HEK293 cells | Decaillot et al., 2011 | ||
Heteromer constitutively recruits β-arrestin-2a | Enhanced cell migrationa | HEK293 cells, MDA-MB-231, U87 cells | Decaillot et al., 2011 | |
Reduced inhibition of cAMP production | HEK293 cells | Decaillot et al., 2011 | ||
Decreased potency for 35GTPγS binding after CXCR4 activation | HEK293 cells | Levoye et al., 2009 | ||
ACKR3 inhibits migration by CXCR4 for low CXCL12 dosea | T lymphocytes | Levoye et al., 2009 |
↵a Controversies between studies.
35GTPγS, guanosine 5′-O-(3-[35S]thio)triphosphate; JAK2, Janus kinase 2; MAPK, mitogen-activated protein kinase; PB, peripheral blood; SAPK, stress-activated protein kinase; STAT3, signal transducer and activator of transcription 3.